PharmaPendium resources and support

Factsheets

• PharmaPendiumopens in new tab/window

• PharmaPendium AI opens in new tab/window

Conference posters

Society of Toxicologyで発表されたポスターを通じて、エルゼビアのAIソリューションが、創薬、開発、規制に関する意思決定において、重要な知見をどのように提供しているかをご確認いただけます。各ポスターでは具体的な事例を取り上げ、高品質なエビデンス、AI、革新的なフレームワークやアプローチが、医薬品開発における成果の向上にどのように貢献しているかをご紹介しています。

• Harnessing artificial intelligence to advance clinical pharmacology and DMPK in drug developmentopens in new tab/window

• Assessing the risk of adverse drug reactions through safety margin analysis: Methodologies and applications in polypharmacyopens in new tab/window

• From monospecific to bispecific: Comparative safety of T‑cell engagers BsAbs versus monospecific agents using clinical outcomes and FAERS dataopens in new tab/window

• Advancing target identification and lead optimization through mechanistic toxicology: An AI-integrated approach for translational safety assessmentopens in new tab/window

• Integrating toxicological and economic evidence to optimize repurposing strategies for rare diseasesopens in new tab/window

Webinars

• How DDI predictions using a static approach can support FDA and EMA drug submission and labellingopens in new tab/window, Olivier Barberan, Director of Translational Medicine Solutions, Elsevier

• Improving clinical trial strategy and efficiency with PharmaPendium’s Efficacy Moduleopens in new tab/window, Pooja Jain, Senior Product Manager, Elsevier